The mystery of what’s causing young people’s cancer leads to the gut

UC expert featured in Wall Street Journal article

The University of Cincinnati Cancer Center's Jordan Kharofa was featured in a Wall Street Journal article discussing the role of diet and the gut in rising levels of gastrointestinal (GI) cancers among young people.

GI cancer rates among people under 50 are increasing worldwide. Colorectal cancer is the leading cause of cancer death in the U.S. in men under 50 and second for women behind breast cancer. As these rates increase, more researchers including Kharofa have turned to the gut for answers.

“There’s an interplay most likely between the things we eat, the bacteria in the gut, and what those bacteria produce,” said Kharofa, MD, a Cancer Center physician researcher and associate professor and vice chair of education in the Department of Radiation Oncology in UC's College of Medicine.

Kharofa's research has found one species of bacteria in the gut that is associated with a sulfur microbial diet, or a diet that is both high in processed meats, low-calorie drinks and liquor and low in raw fruits, vegetables and legumes, is found in higher levels in young colorectal cancer patients.

Read more about Kharofa's research.

Read the Wall Street Journal article.

Featured photo at top of colorectal cancer cells courtesy of the National Cancer Institute.

Related Stories

2

Struggling with daily HIV meds?

March 23, 2026

For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain. As Yahoo!Health recently reported, a new study suggests there may be a better option.

3

Extended-release buprenorphine viable, safe during pregnancy

March 23, 2026

MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.